DBT
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
4 disclosures on record
Evolution of the disclosed total
0%0.2%0.4%0.6%0.8%
Sep 5Sep 10Sep 15Sep 20
Open positions
No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.
Get the moves on DBT by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| September 10, 2026 | Citadel Securities (Europe) Limited | 0.00% | September 14, 2026 |
| September 4, 2026 | Citadel Securities (Europe) Limited | 0.79% | September 14, 2026 |
| September 3, 2026 | Citadel Securities (Europe) Limited | 0.37% | September 8, 2026 |
| August 31, 2026 | Citadel Securities (Europe) Limited | 0.79% | September 8, 2026 |
Download 4 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Ubisoft Entertainment 12.49% of the capital sold short
- Valeo 11.40% of the capital sold short
- Renault 9.16% of the capital sold short
- Viridien 8.08% of the capital sold short
- Teleperformance 7.58% of the capital sold short
- FDJ United 6.19% of the capital sold short
- Abivax 5.10% of the capital sold short
- Elis 4.91% of the capital sold short
- Alstom 4.57% of the capital sold short
- Rémy Cointreau 4.46% of the capital sold short
- Sopra Steria Group 3.92% of the capital sold short
- Spie SA 3.75% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, DBT, source AMF, data as at September 10, 2026, https://www.quivad.com/action/dbt